Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis

Human Molecular Genetics

Volumn 15, Issue 15, 2006, Pages 2298-2312

  Takeshita, Yukio ^a   Fujinaga, Ryutaro ^a   Zhao, Changjiu ^a   Yanai, Akie ^a   Shinoda, Koh ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; HUNTINGTIN; HUNTINGTIN ASSOCIATED PROTEIN 1; POLYGLUTAMINE; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; DELETION MUTANT; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; KENNEDY DISEASE; LIGAND BINDING; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; TISSUE DISTRIBUTION;

ANIMALS; APOPTOSIS; DIHYDROTESTOSTERONE; HUMANS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; MUTANT PROTEINS; NERVE TISSUE PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, ANDROGEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33747884387     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl156     Document Type: Article

References (70)

1. Shinoda, K., Mori, S., Ohtsuki, T. and Osawa, Y. (1992) An aromatase-associated cytoplasmic inclusion, the 'stigmoid body,' in the rat brain: I. Distribution in the forebrain. J. Comp. Neurol., 15, 360-376.
2. Shinoda, K., Nagano, M. and Osawa, Y. (1993) An aromatase-associated cytoplasmic inclusion, the 'stigmoid body,' in the rat brain: II. Ultrastructure (with a review of its history and nomenclature). J. Comp. Neurol., 329, 1-19.
3. Shinoda, K. (1994) Sex-steroid receptor mechanism related to neuronal aromatase and the stigmoid body. Horm. Behav., 28, 545-555.
4. Gutekunst, C.A., Li, S.H., Yi, H., Ferrante, R.J., Li, X.J. and Hersch, S.M. (1998) The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): Comparison with huntingtin in rat and human. J. Neurosci., 18, 7674-7686.
5. Chan, E.Y., Nasir, J., Gutekunst, C.A., Coleman, S., Maclean, A., Maas, A., Metzler, M., Gertsenstein, M., Ross, C.A., Nagy, A. and Hayden, M.R. (2002) Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior. Hum. Mol. Genet., 11, 945-959.
6. Li, S.H., Yu, Z.X., Li, C.L., Nguyen, H.P., Zhou, Y.X., Deng, C. and Li, X.J. (2003) Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J. Neurosci., 23, 6956-6964.
7. Li, S.H., Gutekunst, C.A., Hersch, S.M. and Li, X.J. (1998) Association of HAP1 isoforms with a unique cytoplasmic structure. J. Neurochem., 71, 2178-2185.
8. Page, K.J., Potter, L., Aronni, S., Everitt, B.J. and Dunnett, S.B. (1998) The expression of Huntingtin-associated protein (HAP1) mRNA in developing, adult and ageing rat CNS: Implications for Huntington's disease neuropathology. Eur. J. Neurosci., 10, 1835-1845.
9. Fujinaga, R., Kawano, J., Matsuzaki, Y., Kamei, K., Yanai, A., Sheng, Z., Tanaka, M., Nakahama, K., Nagano, M. and Shinoda, K. (2004) Neuroanatomical distribution of Huntingtin-associated protein 1-mRNA in the male mouse brain. J. Comp. Neurol., 478, 88-109.
10. Li, X.J., Li, S.H., Sharp, A.H., Nucifora, F.C., Jr., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H. and Ross, C.A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature, 378, 398-402.
11. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
12. Folstein, S.E. (1989) In Huntington's Disease: A Disorder of Families, Johns Hopkins, Baltimore, USA.
13. Quarrel, O. and Harper, P.S. (1991) In Harper, P.S. (ed), Huntington's disease, W.B. Saunders, PA, USA, pp. 37-80.
14. Dom, R., Malfoid, M. and Baro, F. (1976) Neuropathology of Huntington's chorea. Neurology, 26, 64-68.
15. Graveland, G.A., Williams, R.S. and DiFiglia, M. (1985) Evidence for degenerative and regenerative changes in neostriatal neurons in Huntington's disease. Science, 227, 770-773.
16. Hedreen, J.C. and Folstein, S.E. (1995) Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol., 54, 105-120.
17. Li, S.H., Schilling, G., Young, W.S., Li, X.J., Margolis, R.L., Stine, O.C., Wagster, M.V., Abbott, M.H., Franz, M.L., Ranen, N.G. et al. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron, 11, 985-993.
18. Bhide, P.G., Day, M., Sapp, E., Schwarz, C., Sheth, A., Kim, J., Young, A.B., Penney, J., Golden, J., Aronin, N. and DiFiglia, M. (1996) Expression of normal and mutant huntingtin in the developing brain. J. Neurosci., 16, 5523-5535.
19. Nasir, J., Duan, K., Nichol, K., Engelender, S., Ashworth, R., Colomer, V., Thomas, S., Disteche, C.M., Hayden, M.R. and Ross, C.A. (1998) Gene structure and map location of the murine homolog of the huntingtin-associated protein, Hap1. Mamm. Genome, 9, 565-570.
20. Nagano, M. and Shinoda, K. (1994) Coexistence of the stigmoid body and estrogen receptor in some neuronal groups involved in rat reproductive functions. Brain Res., 634, 296-304.
21. Sleddens, H.F., Oostra, B.A., Brinkmann, A.O. and Trapman, J. (1992) Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res., 20, 1427.
22. Kennedy, W.R., Alter, M. and Sung, J.H. (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology, 18, 671-680.
23. La Spada, A.R., Roling, D.B., Harding, A.E., Warner, C.L., Spiegel, R., Hausmanowa-Petrusewicz, I., Yee, W.C. and Fischbeck, K.H. (1992) Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat. Genet., 2, 301-304.
24. Li, M., Miwa, S., Kobayashi, Y., Merry, D.E., Yamamoto, M., Tanaka, F., Doyu, M., Hashizume, Y., Fischbeck, K.H. and Sobue, G. (1998) Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann. Neurol., 44, 249-254.
25. Katsuno, M., Adachi, H., Tanaka, F. and Sobue, G. (2004) Spinal and bulbar muscular atrophy: Ligand-dependent pathogenesis and therapeutic perspectives. J. Mol. Med., 82, 298-307.
26. Sobue, G., Hashizume, Y., Mukai, E., Hirayama, M., Mitsuma, T. and Takahashi, A. (1989) X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain, 112, 209-232.
27. Sperfeld, A.D., Karitzky, J., Brummer, D., Schreiber, H., Haussler, J., Ludolph, A.C. and Hanemann, C.O. (2002) X-linked bulbospinal neuronopathy: Kennedy disease. Arch. Neurol., 59, 1921-1926.
28. Diamond, M.I., Robinson, M.R. and Yamamoto, K.R. (2000) Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor. Proc. Natl Acad. Sci. USA, 97, 657-661.
29. Adachi, H., Katsuno, M., Minamiyama, M., Waza, M., Sang, C., Nakagomi, Y., Kobayashi, Y., Tanaka, F., Doyu, M., Inukai, A. et al. (2005) Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain, 128, 659-670.
30. Grierson, A.J., Shaw, C.E. and Miller, C.C. (2001) Androgen induced cell death in SHSY5Y neuroblastoma cells expressing wild-type and spinal bulbar muscular atrophy mutant androgen receptors. Biochim. Biophys. Acta, 1536, 13-20.
31. Kobayashi, Y., Kume, A., Li, M., Doyu, M., Hata, M., Ohtsuka, K. and Sobue, G. (2000) Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J. Biol. Chem., 275, 8772-8778.
32. Takeyama, K., Ito, S., Yamamoto, A., Tanimoto, H., Furutani, T., Kanuka, H., Miura, M., Tabata, T. and Kato, S. (2002) Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron, 35, 855-864.
33. Ross, C.A. (2002) Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron, 35, 819-822.
34. Simental, J.A., Sar, M., Lane, M.V., French, F.S. and Wilson, E.M. (1991) Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem., 266, 510-518.
35. Kuiper, G.G., DeRuiter, P.E. and Brinkmann, A.O. (1993) Androgen receptor phosphorylation. Ann. NY Acad. Sci., 11 (684), 224-226.
36. Zhou, Z.X., Wong, C.I., Sar, M. and Wilson, E.M. (1994) The androgen receptor: An overview. Recent Prog. Horm. Res., 49, 249-274.
37. Kobayashi, Y., Miwa, S., Merry, D.E., Kume, A., Mei, L., Doyu, M. and Sobue, G. (1998) Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner. Biochem. Biophys. Res. Commun., 252, 145-150.
38. Goldberg, Y.P., Nicholson, D.W., Rasper, D.M., Kalchman, M.A., Koide, H.B., Graham, R.K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N.A., Vaillancourt, J.P. and Hayden, M.R. (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet., 13, 442-449.
39. Wang, Y., Pennock, S., Chen, X. and Wang, Z. (2002) Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol. Cell. Biol., 22, 7279-7290.
40. Lee, J.E., Hollenberg, S.M., Snider, L., Turner, D.L., Lipnick, N. and Weintraub, H. (1995) Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science, 268, 836-844.
41. Miyata, T., Maeda, T. and Lee, J.E. (1999) NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev., 13, 1647-1652.
42. Kim, W.Y., Fritzsch, B., Serls, A., Bakel, L.A., Huang, E.J., Reichardt, L., Barth, D.S. and Lee, J.E. (2001) NeuroD-null mice are deaf due to a severe loss of the inner ear sensory neurons during development. Development, 128, 417-426.
43. Pennesi, M.E., Cho, J.H., Yang, Z., Wu, S.H., Zhang, J., Wu, S.M. and Tsai, M.J. (2003) BETA2/NeuroD1 null mice: A new model for transcription factor-dependent photoreceptor degeneration. J Neurosci., 23, 453-461.
44. Olson, J.M., Asakura, A., Snider, L., Hawkes, R., Strand, A., Stoeck, J., Hallahan, A., Pritchard, J. and Tapscott, S.J. (2001) NeuroD2 is necessary for development and survival of central nervous system neurons. Dev. Biol., 234, 174-187.
45. Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B.R., Goffredo, D., Conti, L., MacDonald, M.E., Friedlander, R.M., Silani, V., Hayden, M.R. et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science, 293, 493-498.
46. Luthi-Carter, R., Hanson, S.A., Strand, A.D., Bergstrom, D.A., Chun, W., Peters, N.L., Woods, A.M., Chan, E.Y., Kooperberg, C., Krainc, D. et al. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: Parallel changes in muscle and brain. Hum. Mol. Genet., 11, 1911-1926.
47. Kornblum, H.I., Hussain, R., Wiesen, J., Miettinen, P., Zurcher, S.D., Chow, K., Derynck, R. and Werb, Z. (1998) Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J. Neurosci. Res., 53, 697-717.
48. Sibilia, M., Steinbach, J.P., Stingl, L., Aguzzi, A. and Wagner, E.F. (1998) A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J., 17, 719-731.
49. Li, Y., Chin, L.S., Levey, A.I. and Li, L. (2002) Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J. Biol. Chem., 277, 28212-28221.
50. Sheng, G., Chang, G.Q., Lin, J.Y., Yu, Z.X., Fang, Z.H., Rong, J., Lipton, S.A., Li, S.H., Tong, G., Leibowitz, S.F. and Li, X.J. (2006) Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior. Nat. Med., 5, 526-633.
51. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. and Fischbeck, K.H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77-79.
52. Li, M., Sobue, G., Doyu, M., Mukai, E., Hashizume, Y. and Mitsuma, T. (1995) Primary sensory neurons in X-linked recessive bulbospinal neuropathy: Histopathology and androgen receptor gene expression. Muscle Nerve, 18, 301-308.
53. Mariotti, C., Castellotti, B., Pareyson, D., Testa, D., Eoli, M., Antozzi, C., Silani, V., Marconi, R., Tezzon, F., Siciliano, G. et al. (2000) Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: A clinical and molecular study of 30 families. Neuromuscul. Disord., 10, 391-397.
54. Doyu, M., Sobue, G., Mukai, E., Kachi, T., Yasuda, T., Mitsuma, T. and Takahashi, A. (1992) Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann. Neurol., 32, 707-710.
55. Tanaka, F., Reeves, M.F., Ito, Y., Matsumoto, M., Li, M., Miwa, S., Inukai, A., Yamamoto, M., Doyu, M., Yoshida, M. et al. (1999) Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor gene expression level. Am. J. Hum. Genet., 65, 966-973.
56. Arbizu, T., Santamaria, J., Gomez, J.M., Quilez, A. and Serra, J.P. (1983) A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J. Neurol. Sci., 59, 371-382.
57. Pinsky, L., Trifiro, M., Kaufman, M., Beitel, L.K., Mhatre, A., Kazemi-Esfarjani, P., Sabbaghian, N., Lumbroso, R., Alvarado, C. and Vasiliou, M. (1992) Androgen resistance due to mutation of the androgen receptor. Clin. Invest. Med., 15, 456-472.
58. Brown, T.R., Lubahn, D.B., Wilson, E.M., Joseph, D.R., French, F.S. and Migeon, C.J. (1988) Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: Evidence for further genetic heterogeneity in this syndrome. Proc. Natl Acad. Sci. USA, 85, 8151-8155.
59. Yong, E.L., Chua, K.L., Yang, M., Roy, A. and Ratnam, S. (1994) Complete androgen insensitivity due to a splice-site mutation in the androgen receptor gene and genetic screening with single-stranded conformation polymorphism. Fertil. Steril., 61, 856-862.
60. Katsuno, M., Adachi, H., Doyu, M., Minamiyama, M., Sang, C., Kobayashi, Y., Inukai, A. and Sobue, G. (2003) Leuprolerin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med., 9, 768-773.
61. Simerly, R.B., Chang, C., Muramatsu, M. and Swanson, L.W. (1990) Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study. J. Comp. Neurol., 294, 76-95.
62. Yu, W.H. and McGinnis, M.Y. (2001) Androgen receptors in cranial nerve motor nuclei of male and female rats. J. Neurobiol., 46, 1-10.
63. Rupprecht, R. and Holsbper, F. (1999) Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci., 22, 410-416.
64. Braun, A.M. and Thomas, P. (2004) Biochemical characterization of a membrane androgen receptor in the ovary of the atlantic croaker (Micropogonias undulatus). Biol. Reprod., 71, 146-155.
65. Sperry, T.S. and Thomas, P. (2000) Androgen binding profiles of two distinct nuclear androgen receptors in Atlantic croaker (Micropogonias undulatus). J. Steroid Biochem. Mol. Biol., 73, 93-103.
66. Gao, W., Bohl, C.E. and Dalton, J.T. (2005) Chemistry and structural biology of androgen receptor. Chem. Rev., 105, 3352-3370.
67. Ellerby, L.M., Hackam, A.S., Propp, S.S., Ellerby, H.M., Rabizadeh, S., Cashman, N.R., Trifiro, M.A., Pinsky, L., Wellington, C.L., Salvesen, G.S., Hayden, M.R. and Bredesen, D.E. (1999) Kennedy's disease: Caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J. Neurochem., 72, 185-195.
68. Jenster, G., van der Korput, H.A., van Vroonhoven, C., van der Kwast, T.H., Trapman, J. and Brinkmann, A.O. (1991) Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol., 5, 1396-1404.
69. Becker, M., Martin, E., Schneikert, J., Krug, H.F. and Cato, A.C. (2000) Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch. J. Cell. Biol., 149, 255-262.
70. Avila, D.M., Allman, D.R., Gallo, J.M. and McPhaul, M.J. (2002) Androgen receptors containing expanded polyglutamine tracts exhibit progressive toxicity when stably expressed in the neuroblastoma cell line, SH-SY 5Y. Exp. Biol. Med., 228, 982-990.